A5004135592- Retinal Diseases and Treatments
- Ocular Oncology and Treatments
- Glaucoma and retinal disorders
- Ocular Infections and Treatments
- Retinal and Optic Conditions
- Intraocular Surgery and Lenses
- Ocular Diseases and Behçet’s Syndrome
- Retinal Imaging and Analysis
- Ocular Surface and Contact Lens
- Retinal and Macular Surgery
- Ocular Disorders and Treatments
- Corneal Surgery and Treatments
- Retinal Development and Disorders
- Corneal surgery and disorders
- Traumatic Ocular and Foreign Body Injuries
- Nonmelanoma Skin Cancer Studies
- Ophthalmology and Eye Disorders
- Syphilis Diagnosis and Treatment
- Cerebral Venous Sinus Thrombosis
- Ophthalmology and Visual Impairment Studies
- Immunotherapy and Immune Responses
- Cutaneous Melanoma Detection and Management
- Cancer Genomics and Diagnostics
- Drug-Induced Ocular Toxicity
- Photoreceptor and optogenetics research
Hôpital Pasteur
2016-2025
Université Côte d'Azur
2015-2025
Hôpital Saint Roch
2010-2025
Centre Hospitalier Universitaire de Nice
2016-2025
Observatoire de la Côte d’Azur
2019-2024
Institut de Biologie Valrose
2020-2024
Inserm
2020-2022
Ophthalmology Associates (United States)
2021
Centre Méditerranéen de Médecine Moléculaire
2020
Université de Rouen Normandie
2020
/aims. Pseudoxanthoma Elasticum (PXE, OMIM 264800) is an autosomal, recessive, metabolic disorder characterized by progressive ectopic calcification in the skin, vasculature and Bruch's membrane. Variants ABCC6 gene are associated with low plasma pyrophosphate (PPi) concentration. There currently no reference treatment for this chronic debilitating disease. PROPHECI (PyROphosPHate supplementation to fight ECtopIc PseudoXanthoma Elasticum) first phase II, randomized, double-blind,...
<h3>Aim</h3> To assess the effectiveness of intravitreal dexamethasone implants for treating postsurgical macular oedema (PSMO) including Irvine–Gass syndrome and determining predictive factors treatment response. <h3>Methods</h3> Descriptive, observational, retrospective, consecutive, uncontrolled, multicentre, national case series. One hundred patients were included between April 2011 June 2014, with a minimum 1-year follow-up. Patients received implant 0.7 mg at baseline. Clinical...
To compare subfoveal choroidal thickness (SFCT) before and after uneventful cataract surgery using enhanced depth imaging optical coherence tomography (EDI-OCT).A prospective study was conducted on 115 eyes of 95 patients who had phacoemulsification. Measurements SFCT were performed preoperatively, 1 day (D1), 7 days (D7), month (M1), 3 months (M3) the EDI-OCT technique. Central retinal (CRT) measured at M1 M3.The a mean age 76 ± 8.3 years. The baseline 224 75 μm. It showed negative...
<h3>Aim</h3> To assess the effectiveness and safety of intravitreal dexamethasone implants for treating post-surgical macular oedema, including Irvine-Gass syndrome refractory to first-line treatments. <h3>Methods</h3> Descriptive, observational, retrospective, consecutive, uncontrolled, multicentre, national case series. 50 patients were included in study between March 2011 June 2013 with a minimum 6 months follow-up. At baseline, each patient received implant 0.7 mg (Ozurdex)....
To determine the specific location of initial lesion in acute retinal pigment epitheliitis.Four patients diagnosed with epitheliitis were studied. Fundus photographs, fluorescein angiography and indocyanine green angiography, spectral-domain optical coherence tomography findings reviewed.Four healthy young presented onset unilateral decreased vision. Ophthalmoscopy showed macular mottling surrounding yellow hypopigmented areas at level epithelium (RPE). Fluorescein revealed transmission...
In Brief Purpose: To evaluate the efficacy of dexamethasone 0.7-mg intravitreal implant in patients with radiation macular edema after proton beam therapy for choroidal melanoma. Methods: Five patients' charts were retrospectively reviewed. The main outcome measures visual acuity and mean central retinal thickness. Results: All received a dose 60 cobalt gray equivalent. Radiation occurred within time 26 months irradiation. Mean preinjection was 41 Early Treatment Diabetic Retinopathy Study...
To assess the efficacy and safety of a standardised hyperbaric oxygen therapy protocol (HBOT) monitored by fluorescein angiography (FA) in patients with retinal artery occlusion (RAO).
<title>Abstract</title> <bold>Background/Aims: </bold>Assessing periocular inflammation is essential in several disorders, including Thyroid Eye Disease (TED). The Clinical Activity Score (CAS) the most commonly used method to assess orbital inflammation, but associated with significant inter-observer variability. aim of this study was ability Infrared Thermography (IRT) detect TED and other disorders (OOID). <bold>Methods:</bold> A retrospective conducted between March 2020 November 2023....
To explore the predictability of changes in neovascularization morphology on optical coherence tomography angiography (OCTA) relation to exudative activity structural (OCT) eyes with neovascular age-related macular degeneration (nAMD) treated ranibizumab 0.5 mg. Eighty-five 85 patients nAMD, diagnosed less than 1 year prior study entry and mg, were included this longitudinal, prospective study. Included had no feature at inclusion mg a PRN regimen for following 9 months. At each visit OCT...